Keck School Faculty

Scott Atay
Scott Atay
Assistant Professor Of Clinical Surgery
Surgery
1520 San Pablo Street Health Sciences Campus Los Angeles
Dr. Atay specializes in thoracic surgery, with an emphasis on malignant diseases of the chest, including esophageal cancer. He completed his surgical training at Beth Israel Deaconess Medical Center, Harvard Medical School, followed by thoracic fellowship training at MD Anderson Cancer Center. This training included a focus on advanced surgical techniques, both standard minimally invasive (VATS) as well as robotic surgery. He obtained further training at the National Instituties of Health (NIH), NCI Surgery Branch, completing a clinical research fellowship in surgical oncology. At the National Cancer Institute his research focused on genetic alterations in malignant pleural mesothelioma. His current clinical and research efforts focus on multimodality (chemotherapy, immunotherapy, radiation) treatment in addition to surgery for patients with both early and advanced stage disease. When treating patients with cancer, optimal outcomes can only be achieved when multiple specialties come together to provide a comprehensive mulitdisciplinary treatment plan. As part of the USC/Norris Cancer Center patients have access to skilled clinicians, cutting-edge research and clinical trials, as well as a wide array of additional support services. Dr. Atay is committed to delivering compassionate, high quality care, driven by the most up-to-date evidence.

Sublobar or Suboptimal: Does Tumor Spread through Air Spaces Signify the End of Sublobar Resections for T1N0 Adenocarcinomas? J Thorac Oncol. 2019 Jan; 14(1):11-12.. View in PubMed

A modern reaffirmation of surgery as the optimal treatment for solitary fibrous tumors of the pleura Ann Thorac Surg. 2018 Oct 23. . View in PubMed

Predictors of trimodality therapy and trends in therapy for malignant pleural mesothelioma Eur J Cardiothorac Surg. 2018 May 01; 53(5):960-966. . View in PubMed

Predictors of trimodality therapy and trends in therapy for malignant pleural mesothelioma Eur J Cardiothorac Surg. 2018 05 01; 53(5):960-966. . View in PubMed

Perioperative Outcomes of Patients Undergoing Lobectomy on Clopidogrel Ann Thorac Surg. 2017 Dec; 104(6):1821-1828. . View in PubMed

Long-Term Survival Outcomes of Cancer-Directed Surgery for Malignant Pleural Mesothelioma: Propensity Score Matching Analysis J Clin Oncol. 2017 Oct 10; 35(29):3354-3362. . View in PubMed

Adjuvant chemotherapy following trimodality therapy for esophageal carcinoma-Is the evidence sufficient? J Thorac Dis. 2017 Oct; 9(10):3626-3629.. View in PubMed

Systolic anterior motion of the mitral valve-the mechanism of postural hypotension following left intrapericardial pneumonectomy J Thorac Dis. 2017 Apr; 9(4):E354-E357. . View in PubMed

Fluctuations in Spinal Cord Perfusion Pressure: A Harbinger of Delayed Paraplegia After Thoracoabdominal Aortic Repair Semin Thorac Cardiovasc Surg. 2017 Winter; 29(4):451-459. . View in PubMed

Compromise Not Required Semin Thorac Cardiovasc Surg. 2017; 29(3):426-427. . View in PubMed

Fluctuations in Spinal Cord Perfusion Pressure: A Harbinger of Delayed Paraplegia After Thoracoabdominal Aortic Repair Semin Thorac Cardiovasc Surg. 2017; 29(4):451-459. . View in PubMed

Redo aortic root replacement reutilizing 22-year patent modified Cabrol grafts Eur J Cardiothorac Surg. 2017 04 01; 51(4):794-796. . View in PubMed

Compromise Not Required Semin Thorac Cardiovasc Surg. 2017 Autumn; 29(3):426-427. . View in PubMed

Mithramycin Depletes Specificity Protein 1 and Activates p53 to Mediate Senescence and Apoptosis of Malignant Pleural Mesothelioma Cells Clin Cancer Res. 2016 Mar 01; 22(5):1197-210. . View in PubMed

Empyema necessitans caused by actinomycosis: A case report Int J Surg Case Rep. 2016; 23:182-5. . View in PubMed

Surgery for Li Fraumeni syndrome: pushing the limits of surgical oncology Am J Clin Oncol. 2015 Feb; 38(1):98-102. . View in PubMed

Telomerase variant A279T induces telomere dysfunction and inhibits non-canonical telomerase activity in esophageal carcinomas PLoS One. 2014; 9(7):e101010. . View in PubMed

Aryl hydrocarbon receptor-induced adrenomedullin mediates cigarette smoke carcinogenicity in humans and mice Cancer Res. 2012 Nov 15; 72(22):5790-800. . View in PubMed

Mithramycin represses basal and cigarette smoke-induced expression of ABCG2 and inhibits stem cell signaling in lung and esophageal cancer cells Cancer Res. 2012 Aug 15; 72(16):4178-92. . View in PubMed

Powered by SC CTSI
Go to Top